Facebook Instagram Twitter RSS Feed PodBean Back to top on side

Information Page of SAS Employee

Publications

RNDr. Ing. Katarína Kaľavská, PhD.

On this page, you can search the on-line database of the Slovak Academy of Sciences for the publications.

Select year/category for a list of publications:
  • KUČEROVÁ, Lucia** - FEKIAČOVÁ, Adriana* - UDVORKOVÁ, Natália - MALCHARKOVÁ, Pavlína - BLAHOVÁ, Viktória - JOCHOVÁ, Silvia - KAĽAVSKÁ, Katarína - ČIERNA, Zuzana - MEGO, Michal. Mirvetuximab soravtansine induces potent cytotoxicity and bystander effect in cisplatin-resistant germ cell tumor cells. In Cells, 2025, vol. 14, no. 4, art. no. 287. (2024: 5.2 - IF, Q2 - JCR, 1.67 - SJR, Q1 - SJR). ISSN 2073-4409. Dostupné na: https://doi.org/10.3390/cells14040287 Type: ADMA
  • ORSZÁGHOVÁ, Zuzana - SVETLOVSKÁ, Daniela - LEŠKO, Peter - SYČOVÁ-MILÁ, Zuzana - OBERTOVÁ, Jana - PALACKA, Patrik - REJLEKOVÁ, Katarína - KAĽAVSKÁ, Katarína - MLADOSIEVIČOVÁ, Beata - MARDIAK, Jozef - MEGO, Michal - CHOVANEC, Michal. Longitudinal assessment of cognitive function in survivors of testicular germ cell tumor. In European Urology Oncology, 2025, vol. 8, no. 2, p. 460-468. (2024: 9.3 - IF, Q1 - JCR, 3.419 - SJR, Q1 - SJR). ISSN 2588-9311. Dostupné na: https://doi.org/10.1016/j.euo.2024.12.003 (APVV-15-0086 : Identifikácia biomarkerov asociovaných s neskorou toxicitou chemoterapie u germinatívnych nádorov testis. APVV-19-0411 : Identifikácia a validácia biomarkerov a zodpovedných molekulárnych dráh neskorej toxicity kuratívnej liečby u germinatívnych nádorov testis. VEGA 1/0327/19 : Identifikácia úlohy mikrobiómu a imunitných molekulárnych mechanizmov kognitínych dysfunkcií následkom neskorej toxicity liečby u germinatívnych nádorov testis.) Type: ADCA
  • UDVORKOVÁ, Natália - BLAHOVÁ, Viktória - MALCHARKOVÁ, Pavlína - JOCHOVÁ, Silvia - KAĽAVSKÁ, Katarína - FEKIAČOVÁ, Adriana - PAVEL, Jaroslav - HORAK, Samuel - DŽONGOV, Andrej - JANKO, Jakub - PASTOREK, Michal - CHOVANEC, Michal - ČIERNA, Zuzana - MEGO, Michal* - KUČEROVÁ, Lucia*. Therapeutic efficacy of sacituzumab govitecan in recurrent refractory germ cell tumors. In Biomedicine & Pharmacotherapy, 2025, vol. 192, art. no. 118659. (2024: 7.5 - IF, Q1 - JCR, 1.775 - SJR, Q1 - SJR). ISSN 0753-3322. (APVV-20-0158 : Identifikácia nových možností liečby u refraktérnych testikulárnych nádorov zárodočných buniek.) Type:
Citation, reviews:
1.1 Citations in foreign publications registered in citation indexes Web of Science Core Collection
1.2 Citations in foreign publications registered in Scopus
2.1 Citations in domestic publications registered in citation indexes Web of Science Core Collection
2.2 Citations in domestic publications registered in Scopus
*3 Citations in foreign publications not registered in citation indexes
3.1 Citations in foreign publications not registered in citation indexes
3.2 Citations in foreign publications registered in scientific citation databases other than Web of Science Core Collection or Scopus
*4 Citations in domestic publications not registered in citation indexes
4.1 Citations in domestic publications not registered in citation indexes
4.2 Citations in domestic publications registered in scientific citation databases other than Web of Science Core Collection or Scopus
5 Reviews in foreign publications
6 Reviews in domestic publications
7 Art critiques – foreign
8 Art critiques – domestic
9 Reproductions of artistic works of the author in foreign publications or media
*9 Citations in foreign publications registered in scientific citation databases other than Web of Science Core Collection or Scopus
10 Reproductions of artistic works of the author in domestic publications or media
*10 Citations in domestic publications registered in scientific citation databases other than Web of Science Core Collection or Scopus